MM
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT : report from SFGM-TC | Bone marrow transplantation |  | 2024 | 34 | 0 | ||
| Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis | Transplant infectious disease |  | 2024 | 29 | 23 | ||
| Routine infectious disease consultation prior to an allogeneic hematopoietic cell transplant | Open forum infectious diseases | | 2023 | 39 | 33 | ||
| Revisiting cytomegalovirus serology in allogeneic hematopoietic cell transplant recipients | Clinical infectious diseases | | 2023 | 73 | 37 | ||
| Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant | Open forum infectious diseases | | 2023 | 40 | 31 | ||
| Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation : A Retrospective Study | Transplantation and cellular therapy | | 2022 | 104 | 51 | ||
| The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft | Bone marrow transplantation | | 2021 | 280 | 0 | ||
| Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted Grafts | Biology of Blood and Marrow Transplantation | | 2020 | 275 | 190 |
